Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
2015 · The Breast · 25 citations
https://doi.org/10.1016/j.breast.2015.11.006
M
Mükremın Uysal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
126
Papers
1.0K
Citations
17
h-index
35
i10-index
Mükremın Uysal is an academic researcher from Dokuz Eylül University. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Cancer Diagnosis and Treatment. The author has an h-index of 17, co-authored 108 publications.
ORCID: 0000-0002-8524-0665Papers by this author
worksUse of chemotherapy at the end of life in Turkey
2014 · BMC Palliative Care · 20 citations
https://doi.org/10.1186/1472-684x-13-51
AFYON KOCATEPE ÜNİVERSİTESİ’NDE MEME KANSERİ TANISI İLE TAKİP EDİLMEKTE OLAN HASTALARDA TAMAMLAYICI VE ALTERNATİF TEDAVİ KULLANIMI
2018 · Kocatepe tıp dergisi. · 14 citations
https://doi.org/10.18229/kocatepetip.419014
The importance of COX-2 expression as prognostic factor in early breast cancer.
2014 · PubMed · 12 citations
Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)
2018 · Clinical and Applied Thrombosis/Hemostasis · 9 citations
https://doi.org/10.1177/1076029617753538
Intraarticular hemorrhage due to bevacizumab in a patient with metastatic colorectal cancer: a case report
2012 · Journal of Medical Case Reports · 5 citations
https://doi.org/10.1186/1752-1947-6-188
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat